Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy Mottl

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Clinical Journal of the American Society of Nephrology : CJASN|June 1, 2022
Moving from Evidence to Implementation of Breakthrough Therapies for Diabetic Kidney DiseaseKatherine R Tuttle, Leslie Wong, Wendy St Peter, et al.
Research Square|June 9, 2023
Insights from rare variants into the genetic architecture and biology of youth-onset type 2 diabetesSoo Heon Kwak, Shylaja Srinivasan, Ling Chen, et al.
Journal of the American College of Cardiology|January 6, 2026
Risk of Hyperkalemia With Empagliflozin, Finerenone, or Both: Secondary Analysis of the CONFIDENCE Randomized TrialRajiv Agarwal, Jennifer B Green, Hiddo J L Heerspink, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 31, 2025
Simultaneous initiation of finerenone and empagliflozin across the spectrum of kidney risk in the CONFIDENCE trialMuthiah Vaduganathan, Jennifer B Green, Hiddo J L Heerspink, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 15, 2026
Percutaneous Native Kidney Biopsy Complications in Diabetic Patients in the TRIDENT CohortSamer Mohandes, Mohammad Fakhreddine, Henry Sheng, et al.
Clinical Journal of the American Society of Nephrology : CJASN|September 18, 2025
Impact of Simultaneous Initiation of Finerenone and Empagliflozin on Urinary Albumin-to-Creatinine Ratio in Asia: Pre-Specified Analysis of CONFIDENCERajiv Agarwal, Jennifer B Green, Hiddo J L Heerspink, et al.
Diabetes Care|April 12, 2023
Prevalence, Progression, and Modifiable Risk Factors for Diabetic Retinopathy in Youth and Young Adults With Youth-Onset Type 1 and Type 2 Diabetes: The SEARCH for Diabetes in Youth StudyElizabeth T Jensen, Joseph Rigdon, Kasra A Rezaei, et al.
Human Genetics|July 11, 2009
Genetic influence on variation in serum uric acid in American Indians: the strong heart family studyV Saroja Voruganti, Harald H H Göring, Amy Mottl, et al.
Journal of the American Heart Association|March 30, 2023
Exploring Racial and Ethnic Differences in Arterial Stiffness Among Youth and Young Adults With Type 1 DiabetesKatherine A Sauder, Deborah H Glueck, Kylie K Harrall, et al.
Kidney Medicine|February 2, 2026
Case Series of Histopathological Findings in Chronic Kidney Disease: Insights From the Kidney Precision Medicine ProjectChristine P Limonte, Stephanie Aw, Charles E Alpers, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Clinical Journal of the American Society of Nephrology : CJASN|June 1, 2022
Moving from Evidence to Implementation of Breakthrough Therapies for Diabetic Kidney DiseaseKatherine R Tuttle, Leslie Wong, Wendy St Peter, et al.
Research Square|June 9, 2023
Insights from rare variants into the genetic architecture and biology of youth-onset type 2 diabetesSoo Heon Kwak, Shylaja Srinivasan, Ling Chen, et al.
Journal of the American College of Cardiology|January 6, 2026
Risk of Hyperkalemia With Empagliflozin, Finerenone, or Both: Secondary Analysis of the CONFIDENCE Randomized TrialRajiv Agarwal, Jennifer B Green, Hiddo J L Heerspink, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 31, 2025
Simultaneous initiation of finerenone and empagliflozin across the spectrum of kidney risk in the CONFIDENCE trialMuthiah Vaduganathan, Jennifer B Green, Hiddo J L Heerspink, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 15, 2026
Percutaneous Native Kidney Biopsy Complications in Diabetic Patients in the TRIDENT CohortSamer Mohandes, Mohammad Fakhreddine, Henry Sheng, et al.
Clinical Journal of the American Society of Nephrology : CJASN|September 18, 2025
Impact of Simultaneous Initiation of Finerenone and Empagliflozin on Urinary Albumin-to-Creatinine Ratio in Asia: Pre-Specified Analysis of CONFIDENCERajiv Agarwal, Jennifer B Green, Hiddo J L Heerspink, et al.
Diabetes Care|April 12, 2023
Prevalence, Progression, and Modifiable Risk Factors for Diabetic Retinopathy in Youth and Young Adults With Youth-Onset Type 1 and Type 2 Diabetes: The SEARCH for Diabetes in Youth StudyElizabeth T Jensen, Joseph Rigdon, Kasra A Rezaei, et al.
Human Genetics|July 11, 2009
Genetic influence on variation in serum uric acid in American Indians: the strong heart family studyV Saroja Voruganti, Harald H H Göring, Amy Mottl, et al.
Journal of the American Heart Association|March 30, 2023
Exploring Racial and Ethnic Differences in Arterial Stiffness Among Youth and Young Adults With Type 1 DiabetesKatherine A Sauder, Deborah H Glueck, Kylie K Harrall, et al.
Kidney Medicine|February 2, 2026
Case Series of Histopathological Findings in Chronic Kidney Disease: Insights From the Kidney Precision Medicine ProjectChristine P Limonte, Stephanie Aw, Charles E Alpers, et al.
Pageof 3